Point of care CD19 chimeric antigen receptor (CAR) T-cells for relapsed/refractory acute myeloid leukemia (AML) with aberrant CD19 antigen expression
- 15 September 2024
- journal article
- research article
- Published by Elsevier in Current Research in Translational Medicine
- Vol. 72 (4) , 103471
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Cancer Institute (P30 CA008748, K08CA282987)
This publication has 41 references indexed in Scilit:
- ASTCT Clinical Practice Recommendations for Transplantation and Cellular Therapies in Multiple MyelomaTransplantation and Cellular Therapy, 2022
- Point-of-care anti-CD19 CAR T-cells for treatment of relapsed and refractory aggressive B-cell lymphomaTransplantation and Cellular Therapy, 2022
- CAR-T Cell Therapy for Acute Myeloid Leukemia: Preclinical Rationale, Current Clinical Progress, and Barriers to SuccessBioDrugs, 2021
- Treatment of Relapsed Acute Myeloid LeukemiaCurrent Treatment Options in Oncology, 2020
- Anti-CD19 CAR T-Cell Therapy for B-Cell Non-Hodgkin LymphomaTransfusion Medicine Reviews, 2020
- Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysisThe Lancet Haematology, 2019
- ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector CellsTransplantation and Cellular Therapy, 2019
- Locally produced CD19 CAR T cells leading to clinical remissions in medullary and extramedullary relapsed acute lymphoblastic leukemiaAmerican Journal of Hematology, 2018
- Leukemic stem cells: identification and clinical applicationInternational Journal of Hematology, 2017
- Proceedings from the National Cancer Institute’s Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: Part III. Prevention and Treatment of Relapse after Allogeneic TransplantationTransplantation and Cellular Therapy, 2014